// App-Quantinova.ai

826 : Benzyl isothiocyanate inhibits breast cancer-induced osteoclastogenesis

Researchers

Presenter

  • Subrata K. Pore

Principal Investigators

  • Anuradha Sehrawat

  • Shivendra V. Singh

Medical Centers

  • UNIVERSITY OF PITTSBURGH, Pittsburgh, PA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bone metastases

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Osteoprotegerin

  • Colony stimulating factor 1

  • Receptor activator of nuclear factor kappa-Β ligand

  • Granulocyte-macrophage-colony stimulating factor

  • Interleukin 6

Drug/Treatment

  • GM-CSF

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A